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Background: Perirenal hematomas are most frequently caused by neoplasm, followed by polyarteritis nodosa (PN),
but may also be a rare complication of MPA.
Case Presentation: A 77-year-old woman who presented with rapidly progressive glomerulonephritis, proteinuria,
and mononeuropathy multiplex, and was positive for serum myeloperoxidase-anti-neutrophil cytoplasmic antibody,
was diagnosed with vasculitis as a probable microscopic polyangiitis (MPA). She developed a spontaneous right-sided
perirenal hematoma, along with back pain, on the day of referral to the nephrology unit and a spontaneous left-sided
perirenal hematoma ten days later. Treatment with 30 mg/day prednisolone stabilized the hematomas and controlled
the progression of probable MPA.
Conclusion: Nephrectomy or embolization is commonly required in patients with perirenal hematoma
associated with neoplasm or PN, but radical invasive management may not be necessary in patients with
MPA because smaller blood vessels are affected, resulting in less extensive bleeding and normal clotting.
Accurate differential diagnosis between MPA and PN is essential to avoid invasive management of perirenal
hematomas in patients with MPA. The presence of glomerulonephritis suggests injury to capillary vessels, a
characteristic of MPA.
Keywords: Spontaneous perirenal hematoma, Microscopic polyangiitis, Polyarteritis nodosa, Non-surgical treatmentBackground
Microscopic polyangiitis (MPA) can be distinguished from
polyarteritis nodosa (PN) by the size of affected vessels
[1]. MPA is defined as pauci-immune necrotizing vascu-
litis affecting small vessels, with or without involvement of
medium-sized arteries, whereas PN is defined as arteritis
of small- and medium-sized arteries without involvement
of smaller vessels. However, the clinical manifestations of
MPA and PN are similar. Spontaneous perirenal
hematoma is not uncommon in patients with PN, but is
rare in patients with MPA. Aggressive treatment,* Correspondence: mimat@wakayama-med.ac.jp
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nal hematoma in patients with PN, but the optimum treat-
ment of perirenal hematomas in patients with MPA
remains undetermined.
This report describes a patient with vasculitis as a
probable MPA and bilateral spontaneous perirenal he-
matomas, as well as her treatment and outcome.Case presentation
A 77-year-old woman experienced neck pain, weakness in
both arms, and nocturnal fever, followed 1 month later by
leg edema and palsy, gait disorder, and pain in the arms.
Two months after, she first felt ill; her family doctor diag-
nosed her with polymyalgia rheumatica and prescribed
10 mg/day prednisolone (PSL). Her renal function wasticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Red blood cells 317 × 10^4 /μL
Hemoglobin 8.6 g/dL
Hematocrit 26.50 %




Platelet 32.5 × 10^4 /μL
Blood chemistry
Total protein 4.7 g/dL



















Anti-nuclear Ab 80 T












Table 1 The data of blood and urinary sediment examination at
the nephrology referral (Continued)
Endocrinology
Thyroid-stimulating hormone 3.29 uIU/mL
Free triiodothyronine 3 1.12 pg/mL
Urinalysis






Squamous epithelial cell 5–9/HPF
Granular cast 1–9 /LPF
Hyaline cast 1–9/WF
FENa (%) 1.90 %
FEUN (%) 50 %
AST aspartate aminotransferase, ALT alanin aminotransferase, LDH lactate
dehydrogenase, CK creatinine kinase, BUN blood urea nitrogen, CRP C-reactive
protein, MPO-ANCA perinuclear anti-neutrophil cytoplasmic antibody, PR3-ANCA
cytoplasmic anti-neutrophil cytoplasmic antibody, ASO anti-streotolysin O
antibody, PT-INR prothrombin time-international normalized ratio, APTT
activated partial thromboplastin time, FDP fibrin degradation product,
FENa fractional exertion of sodium, FEUN fractional exertion of urea
nitrogen
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and serum blood urea nitrogen (BUN) was 13.9 mg/dL at
this time. Her symptoms did not improve, and she was
admitted to hospital, where she was diagnosed with infec-
tion and administered antibiotics but without effect. Two
weeks later, by experiencing progressive deterioration in
renal function with an increased serum concentration of
myeloperoxidase-anti-neutrophil cytoplasmic antibody
(MPO-ANCA), she was suspected as MPA and referred to
the nephrology unit.
Physical examination showed her body temperature was
37.0 °C, her blood pressure was 160/100 mmHg, and her
pulse was 98 beats/min and regular. She had clear conscious-
ness but experienced motor and sensory paresis and pitting
edema of the arms and legs. No remarkable findings were ob-
served in her chest and abdomen, although she complained of
right back pain. Laboratory tests revealed an increased white
blood cell count of 18,200/μL and anemia with 8.6 g/dL
hemoglobin. The serum level of creatinine was 1.03 mg/dL.
Her blood urea nitrogen (BUN) was elevated at 42 mg/dL,
her C-reactive protein (CRP) was 11.43 mg/dL, and her
MPO-ANCA was 112.0 EU. Prothrombin time (PT)-INR was
1.91, fibrinogen was 631 mg/dl, and activated partial thrombo-
plastin time (APTT) was 35.2. Urinalysis showed proteinuria,
microscopic hematuria, renal tubular epithelial cells, and
granular casts (Table 1). Bacterial culture of her pharynx, ex-
pectorate, and blood revealed no significant findings.
Fig. 1 Abdominal enhanced CT imaging of a subcapsular hematoma
of the right kidney on day 1
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referral to the nephrology unit showed a subcapsular
hematoma of the right kidney (Fig. 1), which had not
been apparent on the last CT image obtained before
referral to the unit. We diagnosed her with rapidly pro-
gressive glomerulonephritis by an experiencing progres-
sive deterioration in renal function with presence of
proteinuria, microscopic hematuria, and cellular casts. A
renal biopsy could not be done because of perirenal
hematoma, so it was impossible to histologically diag-
nose. However, she was fulfilled with probable MPA, so
we decided to treat her with 30 mg/day of PSL on the
ninth day after referral. On day 10, however, she com-
plained of left back pain. Abdominal CT and ultrasonog-
raphy showed bilateral perirenal hematomas (Fig. 2a, b)
and laboratory testing revealed severe anemia with a
hemoglobin concentration of 7.2 g/dL. On days 21 and
22, she underwent hemodialysis because her serum con-
centrations of creatinine (2.70 mg/dL) and BUN
(128 mg/dL) had increased; however, her CRP level nor-
malized after she was started on PSL (Fig. 3a, b). AfterFig. 2 Abdominal CT imaging and ultrasonography on day 10. a Abdomin
area in front of vertebral bone was the intervertebral disc and the iliopsoas
b The photograph of ultrasonography of the left kidney on day 10that, her renal function became better and hemodialysis
was terminated by decrease in activity of vasculitis. On
day 37, the dosage of PSL was reduced to 27.5 mg/day,
CT showed that hematoma had not increased in size,
and her hemoglobin level was increasing. On day 49, her
renal function became better (serum level of creatinine
was 1.83 mg/dL and BUN was 50 mg/dL) and she was
transferred to the previous hospital.
Discussion
In this case, we concluded that her experiencing pro-
gressive deterioration in renal function was caused by
rapidly progressive glomerulonephritis (RPGN) because
of the following reasons. There was a finding of nephritis
in her urinalysis analysis, and no evidence of postrenal
failure in the enhanced abdominal CT. And the frac-
tional excretion of sodium (FENa) and fractional excre-
tion of urea nitrogen (FEUN) proved that her renal
failure was not due to a prerenal cause. Moreover, al-
though the worsening of her renal function might be
caused by perirenal hematoma, there is a report that
renal function was not worse in renal hematoma due to
tumor, which did not affect in glomeruli [2]. RPGN and
MPO-ANCA-positive suspected MPA in this patient.
Definite MPA is diagnosed by the existence of both
RPGN and pulmonary complications or definitive histo-
pathological changes in a target organ. Renal biopsy was
necessary to diagnose this patient as definite MPA. How-
ever, we decided not to perform renal biopsy in this pa-
tient whose right kidney had perirenal hematoma at the
time of referral to the nephrology unit because renal bi-
opsy in the right kidney had a high risk of induction of
retroperitoneum hemorrhage and renal biopsy in the left
kidney could not be done caused by equal in single kid-
ney. Then, we diagnosed her as probable MPA and the
worsening of her renal function was thought to be
caused by probable MPA. Indeed, her renal functional CT imaging of bilateral perirenal hematomas on day 10. The density
muscle. These were also found in another slice of first abdominal CT.
Fig. 3 Clinical course of the patient. a Change of serum levels of MPO-ANCA and CRP. b Change of serum levels of creatinine and BUN.
PSL prednisolone, Hb hemoglobin, CRP C-reactive protein, MPO-ANCA myeloperoxidase-antineutrophil cytoplasmic antibody, Cre creatinine,
BUN blood urea nitrogen
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with the existence of bilateral perirenal hematoma by
treatment for probable MPA. Her hematoma was con-
cluded to be induced by probable MPA because an ar-
teriovenous malformation, an aneurysm, or a kidney
tumor was not found and enhanced agent was not
leaked in other perirenal hematoma in enhanced CT.
And the hematoma was not thought to be caused by her
coagulation disorder, because her extended PT time was
caused by coagulation after drawing blood due to high
level of fibrinogen, which was often observed in the in-
flammatory diseases such as rheumatoid arthritis, and
the tendency to bleed such as subcutaneous and nose
hemorrhage was not observed.
Spontaneous subcapsular or perirenal hemorrhage is a
relatively uncommon complication that often requires
additional treatment [3, 4]. A total of 165 patients with
this complication were reported between 1985 and 1999
[5]. The most common cause was benign or malignant
neoplasm (101 patients, 61 %), followed by vascular dis-
eases (28 patients, 17 %). Of the latter, PN was most
often reported (20 patients, 12.1 %), with other vasculit-
ides being rare, including three patients with aneurysm,
two with infarction, and one each with arteriovenous
malformation (AVM), granulomatosis with polyangiitis
(GPA) [4], and portal hypertension [5].
Although rare in patients with PN, spontaneous sub-
capsular or perirenal hemorrhage is even rarer inpatients with MPA. Most reports of this complication in
patients with MPA were from Japan, with the incidence
being rarer in other countries. The incidence of MPA has
been found to vary among countries, being higher than
GPA in Asian countries, especially Japan, but very rare in
western Europe and America. The clinical features of
MPA and PN are similar, but MPA is rarely associated
with perirenal hemorrhage. Smaller vessels are affected in
MPA than in PN, reducing the volume of bleeding from
affected vessels in the former and allowing blood to clot
properly. Therefore, the development of a perirenal
hematoma in a patient with MPA would require many
blood vessels to be simultaneous affected. Furthermore,
MPA was often confused with PN, but the two conditions
can now be distinguished by the size of the affected
vessels. Briefly, small-sized vessels are affected in MPA but
not in PN. Thus, the occurrence of proteinuria or glom-
erular hematuria is evidence for vasculitis in a small-sized
glomerular capillary. Indeed, our patient was diagnosed
with MPA by the occurrence of proteinuria.
Seventeen of 20 patients with PN treated for spontan-
eous perirenal hematomas required angioembolization or
nephrectomy, whereas the other three were cured follow-
ing conservative treatment (Table 2) [6–20]. Some of these
patients may actually have had MPA. Treatment of spon-
taneous perirenal hematomas in patients with MPA has
not yet been standardized, inasmuch as only seven pa-
tients to date, including ours, have been reported with this
Table 2 Description of patients with spontaneous perirenal hematomas and vasculitis
Author Diagnosis Proteinuria or hematuria Bilatera/
Unilateral
Angiogram Embolization Nephrectomy Surgical
treatment
Nandwani GM et al. [6] PN N/A Unilateral Done Done Not done +
Mukhopadhyay P et al. [7] PN Proteinuria Bilateral Done Not done Not done −
Yang HC et al. [8] PN N/A Unilateral Done Done Not done +
Diaz JR et al. [9] PN N/A Unilateral Done Done Not done +
Unverdi S et al. [10] PN N/A Bilateral Done Done Not done +
Hidalgo J et al. [11] PN Normal Unilateral Done Done Not done +
Minardi D et al. [12] PN N/A Unilateral N/A N/A Done +
Sgcan A et al. [13] PN Hematuria 5–6/HPF Bilateral Done Not done Not done −
Launay D et al. [14] PN N/A Bilateral Done Done Not done +
Schouffoer AA et al. [15] PN Hematuria Unilateral Done Done Not done +
Akcicek F et al. [16] PN N/A Unilateral Not done Not done Done +
Senaati S et al. [17] PN N/A Unilateral N/A N/A Done +
Basaranoglu M et al. [18] PN Proteinuria and hematuria Bilateral Done Done Not done +
Agarwal A et al. [19] PN Proteinuria and hematuria Bilateral Done Done Not done +
Akiko Hayakawa et al. [20] PN Proteinuria2+, hematuria2+ Unilateral Done Done Not done +
Harada M et al. [2007a] PN N/A Unilateral Done Done Not done +
Tokuyama Y et al. [2001a] PN Proteinuria1+, hematuria3+ Bilateral Done Done Not done +
Ohori K et al. [2000a] PN N/A Bilateral Done Done Not done +
Kurashige T et al. [2004a] PN N/A Unilateral N/A N/A Done +
Kojima T et al. [2009a] PN Proteinuria 40 mg/dl,
hematuria3+
Unilateral Not done Not done Not done −
Kiyosumi R et al. [2011a] MPA N/A Unilateral Done Done Not done +
Tamei N et al. [21] MPA Proteinuria1+, hematuria2+ Unilateral Done Not done Not done −
Morimatsu Y et al. [22] MPA N/A Unilateral Done Done Not done +
Sakai M et al. [2009a] MPA N/A Bilateral Not done Not done Not done −
Ishikawa M et al. [2006a] MPA N/A Unilateral Not done Not done Not done −
Tarui N et al. [2006a] MPA N/A Unilateral Done Not done Not done −
Our case MPA Proteiruria, hematuria Bilateral Not done Not done Not done −
[ ] reference number or published year
aOnly Japanese
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and the other five, included our patient, were cured with
conservative treatment (Table 2) [21]. These indicated that
the rate of invasive treatment in PN was 0.85 (17 cases of
20 cases) and that in MPA was 0.28 (two cases of seven
cases). There was significant difference between the two
groupes (P < 0.01) using the Z test. Thus, invasive treat-
ment was less necessary in patients with MPA than with
PN. Moreover, nephritis and renal failure occur more fre-
quently in patients with MPA than PN, considering
contrast-induced nephrotoxicity, the careful determin-
ation of the angiography would be needed. The rate of
involvement of medium-sized arteries, which often require
invasive treatment, was found to be 23 % in patients with
MPA [22], suggesting that small or microvessels are re-
sponsible for perirenal hematoma in patients with MPA,with no need for angioembolization. Invasive treatment in
patients with MPA may be necessary for extended con-
tinuous bleeding, continuously low blood pressure, pro-
gressive anemia, or increased perirenal hemorrhage.
Ultrasonography of our patient showed no evidence for
increased perirenal hemorrhage. Our findings suggest that
spontaneous perirenal hematomas in patients with MPA
could be treated conservatively, with no signs of continu-
ous bleeding such as continuous low blood pressure, pro-
gressing anemia, and expansion of the hematoma.
Conclusions
Because perirenal hematomas may develop in patients
with MPA, differential diagnosis between MPA and PN
is essential to prevent unnecessary invasive methods,
such as nephrectomy or angiography, in the former. The
Nakashima et al. Renal Replacement Therapy  (2015) 1:8 Page 6 of 6presence of glomerulonephritis, which suggests involve-
ment of smaller vessels, may be useful in differentiating
between these clinically similar diseases.
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